(Z)-Methyl 3-bromo-2-isocyano-3-phenylacrylate | 119826-05-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (Z)-Methyl 3-bromo-2-isocyano-3-phenylacrylate
• 英文别名: methyl (Z)-3-bromo-2-isocyano-3-phenylprop-2-enoate
• CAS: 119826-05-0
• 化学式: C₁₁H₈BrNO₂
• 分子量: 266.094
• InChiKey: LYMAEVMOKYXBHO-KTKRTIGZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  30.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (Z)-Methyl 3-bromo-2-isocyano-3-phenylacrylate 在 sodium hydroxide 、 三乙胺 作用下， 以 甲醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 18.0h， 生成 1-甲基-5-苯基咪唑-4-羧酸
  参考文献：
  名称：

  2-[（2-氨基苄基）亚磺酰基] -1-（2-吡啶基）-1,4,5,6-四氢环戊[d]咪唑类是一类新型的胃H + / K + -ATPase抑制剂。

  摘要：

  合成了2-亚磺酰咪唑类化合物，并研究了其作为胃H + / K（+）-ATPase的潜在抑制剂。发现4,5-未取代的咪唑系列6-11和1,4,5,6-四氢环戊[d]咪唑系列12是酸分泌酶H + / K（+）-ATPase的有效抑制剂。结构-活性关系表明，在咪唑部分的1位上取代了2-吡啶基，并在2位上结合了（2-氨基苄基）-亚磺酰基，导致了具有良好化学稳定性的高活性化合物。咪唑部分中的其他取代方式导致生物活性降低。选择了2-[（2-氨基苄基）亚磺酰基] -1- [2-（3-甲基吡啶基）]-1,4,5,6-四氢环戊++ ++ ++ [d]-咪唑（12h，T-776）作为潜在的临床候选者进行进一步开发。

  DOI：

  10.1021/jm950610n
• 作为产物：
  描述：

  苯甲醛 在 N-溴代丁二酰亚胺(NBS) 、 sodium hydride 、 三乙胺 、 三氯氧磷 作用下， 以 四氢呋喃 、 四氯化碳 为溶剂， 生成 (Z)-Methyl 3-bromo-2-isocyano-3-phenylacrylate
  参考文献：
  名称：

  β-官能化的α，β-脱氢氨基酸衍生物的合成

  摘要：

  通过加成消除途径合成了β-官能化的α，β-不饱和氨基酸。通过将异氰基乙酸甲酯（1）与醛缩合，然后溴化与硫醇反应制得的β-溴-α-甲酰基氨基丙烯酸甲酯（3a-e）反应，得到β-烷硫基-α，β-不饱和氨基酸衍生物（ 6a-f）。（3a）与叠氮化钠的反应导致形成2-氧代咪唑啉衍生物（4）。另一方面，通过由（3a和3d），分别用苄醇和苄胺，然后进行酸性水合。

  DOI：

  10.1016/s0040-4020(01)86052-x

文献信息

• Substituted imidazole compound and use thereof
  申请人：Kuroita Takanobu

  公开号：US20090227560A1

  公开（公告）日：2009-09-10

  The present invention relates to a compound represented by the formula: wherein each symbol is as defined in the description, or a salt thereof or a prodrug thereof. The compound of the present invention has a superior renin inhibitory activity, and thus is useful as an agent for the prophylaxis or treatment of hypertension, various organ damages attributable to hypertension, and the like.

  本发明涉及一种由以下式表示的化合物：其中每个符号如描述中所定义，或其盐或前药。本发明的化合物具有优越的肾素抑制活性，因此可用作预防或治疗高血压、由高血压引起的各种器官损伤等的药物。
• Cyclic Amine Compound and Use Thereof for the Prophylaxis or Treatment of Hypertension
  申请人：Kuroita Takanobu

  公开号：US20100121048A1

  公开（公告）日：2010-05-13

  The present invention relates to a compound represented by the formula: (I) wherein ring A is a 5- or 6-membered aromatic heterocycle optionally having substituent (s); U, V and W are each independently C or N, provided that when any one of U, V and W is N, then the others should be C; Ra and Rb are each independently a cyclic group optionally having substituent(s), a C 1-10 alkyl group optionally having substituent(s), a C 2-10 alkenyl group optionally having substituent(s), or a C 2-10 alkynyl group optionally having substituent(s); X is a bond, or a spacer having 1 to 6 atoms in the main chain; Y is a spacer having 1 to 6 atoms in the main chain; Rc is a hydrocarbon group optionally containing heteroatom(s) as the constituting atom(s), which optionally has substituent(s); m and n are each independently 1 or 2; and ring B optionally further has substituent(s), or a salt thereof. The compound of the present invention has excellent renin inhibitory activity, and thus is useful as an agent for the prophylaxis or treatment of hypertension, various organ damages attributable to hypertension, and the like.

  本发明涉及一种由式(I)表示的化合物：其中，环A是一种5或6成员的芳香杂环，可选地具有取代基；U、V和W分别独立地为C或N，但当U、V和W中的任何一个为N时，其他的应为C；Ra和Rb分别独立地为一个环状基团，可选地具有取代基；一个C1-10烷基，可选地具有取代基；一个C2-10烯基，可选地具有取代基；或一个C2-10炔基，可选地具有取代基；X是一条键或具有1到6个原子的主链间隔；Y是具有1到6个原子的主链间隔；Rc是一个含有杂原子作为构成原子的碳氢基团，可选地具有取代基；m和n分别独立地为1或2；环B可选地具有取代基，或其盐。本发明的化合物具有优异的肾素抑制活性，因此可用作预防或治疗高血压、高血压引起的各种器官损伤等的药物。
• Screening Multicomponent Reactions for X-Linked Inhibitor of Apoptosis-Baculoviral Inhibitor of Apoptosis Protein Repeats Domain Binder
  作者：Ilaria Monfardini、Jui-Wen Huang、Barbara Beck、Jason F. Cellitti、Maurizio Pellecchia、Alexander Dömling

  DOI：10.1021/jm101341m

  日期：2011.2.10

  We report a second example of a general reaction screening approach to discover low molecular weight inhibitors of protein protein interactions. On the basis of the known pharmacophore model of SMAC mimetics, we predicted several inhibitors based on four different multicomponent reactions. The predicted inhibitors were subsequently synthesized, tested, and found to bind to the antiapoptotic protein X-linked inhibitor of apoptosis protein (XIAP) and showed cellular activity. Also the compounds are currently not highly potent. They could form a starting point for future medicinal chemistry optimization.
• A Novel Synthesis of Methyl 1,5-Disubstituted Imidazole-4-carboxylates Using 3-Bromo-2-isocyanoacrylates (BICA)
  作者：Ken-ichi Nunami、Masaki Yamada、Toshio Fukui、Kazuo Matsumoto

  DOI：10.1021/jo00104a018

  日期：1994.12

  Methyl 1,5-disubstituted imidazole-4-carboxylates 1 were synthesised using methyl 3-substituted 3-bromo-2-isocyanoacrylates 3 (BICA), and the reaction mechanism was elucidated. Reactions of 3, which were prepared by bromination of 3-substituted 2-(formylamino)acrylates 6 followed by dehydration of the formylamino group, with a variety of primary amines gave imidazoles 1 in good overall yields. A mechanistic study suggested a Michael reaction of an amine with 3 followed by p-elimination of hydrogen bromide exclusively afforded (E)-N,3-disubstituted 3-amino-2-isocyanoacrylates 2. Geometric isomerization to (Z)-2 with a base and subsequent cyclization gave imidazoles 1.
• CYCLIC AMINE COMPOUND AND USE THEREOF FOR THE PROPHYLAXIS OR TREATMENT OF HYPERTENSION
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP1984355A2

  公开（公告）日：2008-10-29